You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Unclassifiable tumor

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Astroblastoma, BCOR ITD Sarcoma, CNS Sarcoma Trial in Washington

Recruiting
  • Astroblastoma
  • +3 more
    • Washington, District of Columbia
      Children's National Hospital
    Jan 23, 2023

    Patients With a Sonographically Unclassifiable Adnexal Mass Using the IOTA Simple Rules Trial in Leuven

    Unknown status
    • Patients With a Sonographically Unclassifiable Adnexal Mass Using the IOTA Simple Rules
    • Diffusion/Perfusion-weighted Magnetic Resonance Imaging
    • Leuven, Belgium
      University Hospitals Leuven
    Apr 12, 2020

    Recurrent B-Cell Lymphoma, Unclassifiable, With Features Intermediate Between DLBCL and Classic Hodgkin Lymphoma, Recurrent

    Not yet recruiting
    • Recurrent B-Cell Lymphoma, Unclassifiable, With Features Intermediate Between Diffuse Large B-Cell Lymphoma and Classic Hodgkin Lymphoma
    • +21 more
    • Biopsy
    • +8 more
    • Columbus, Ohio
      Ohio State University Comprehensive Cancer Center
    Apr 7, 2023

    ALK-Positive Large B-Cell Lymphoma, Burkitt-Like Lymphoma With 11q Aberration, DLBCL Activated B-Cell Type Trial in United

    Active, not recruiting
    • ALK-Positive Large B-Cell Lymphoma
    • +34 more
    • Phoenix, Arizona
    • +32 more
    Jan 3, 2023

    Recurrent ALK Positive Large B-Cell Lymphoma, Recurrent B-Cell Lymphoma, Unclassifiable, With Features Intermediate Between

    Not yet recruiting
    • Recurrent ALK Positive Large B-Cell Lymphoma
    • +28 more
    • Biospecimen Collection
    • +5 more
    • Rochester, Minnesota
      Mayo Clinic in Rochester
    Aug 17, 2022

    Vitiligo Trial in Sohag (Light microscopic studies, Immunohistochemical studies)

    Not yet recruiting
    • Vitiligo
    • Light microscopic studies
    • Immunohistochemical studies
    • Sohag, Egypt
      Sohag University Hospital
    May 19, 2023

    Myelodysplastic/Myeloproliferative Tumor With Ring Sideroblasts and Thrombocytosis, Myelodysplastic/Myeloproliferative Tumor,

    Recruiting
    • Myelodysplastic/Myeloproliferative Neoplasm With Ring Sideroblasts and Thrombocytosis
    • Myelodysplastic/Myeloproliferative Neoplasm, Unclassifiable
    • Rochester, Minnesota
      Mayo Clinic in Rochester
    Jan 6, 2023

    Expression Pattern of HNRNPH1 and HNRNPK Genes in MPNs

    Not yet recruiting
    • Myeloproliferative Neoplasms (MPNs)
    • Reverse transcription-quantitative polymerase chain reaction (RT-qPCR)
    • (no location specified)
    Mar 24, 2023

    Mutations and Phenotypes of Unclassifiable Inherited Bone Marrow

    Recruiting
    • Inherited BMF Syndrome
    • The whole-exome sequencing
    • Sohag, Egypt
      , Faculty of Medicine, Sohag University
    Jun 28, 2022

    Aggressive Non-Hodgkin Lymphoma, Ann Arbor Stage I Primary Mediastinal (Thymic) Large B-Cell Cell Lymphoma, Ann Arbor Stage II

    Active, not recruiting
    • Aggressive Non-Hodgkin Lymphoma
    • +13 more
    • Columbus, Ohio
      Ohio State University Comprehensive Cancer Center
    Aug 18, 2022

    DLBCL Unclassifiable Trial in Houston (Cyclophosphamide, Doxorubicin Hydrochloride, Etoposide)

    Active, not recruiting
    • Diffuse Large B-Cell Lymphoma Unclassifiable
    • Houston, Texas
      M D Anderson Cancer Center
    Feb 23, 2022

    DLBCL, High Grade B-Cell Lymphoma Trial in United States (Venetoclax, Rituximab, Etoposide)

    Completed
    • Diffuse Large B-Cell Lymphoma
    • High Grade B-Cell Lymphoma
    • Boston, Massachusetts
    • +5 more
    Aug 23, 2022

    Brain and CNS Tumors, Chronic Myeloproliferative Disorders, Leukemia Trial in Detroit (3'-deoxy-3'-[18F]fluorothymidine)

    Recruiting
    • Brain and Central Nervous System Tumors
    • +8 more
    • 3'-deoxy-3'-[18F]fluorothymidine
    • Detroit, Michigan
      Barbara Ann Karmanos Cancer Institute
    Mar 30, 2022

    Novel Coronavirus-induced Lung Fibrosis Trial in Chandigarh (Pirfenidone, Nintedanib)

    Active, not recruiting
    • Novel Coronavirus-induced Lung Fibrosis
    • Chandigarh, India
      Postgraduate Institute of Medical Education and Research
    Sep 30, 2022

    DLBCL Unclassifiable, Recurrent DLBCL, Recurrent Primary Mediastinal (Thymic) Large B-Cell Cell Lymphoma Trial in Duarte,

    Recruiting
    • Diffuse Large B-Cell Lymphoma Unclassifiable
    • +6 more
    • Duarte, California
    • +1 more
    Oct 1, 2021

    Collecting and Storing Blood Samples From Patients With Cancer

    Withdrawn
    • Brain and Central Nervous System Tumors
    • +10 more
      • (no location specified)
      Sep 20, 2021

      Unknown Primary Tumors, Oropharynx Cancer Trial in Groningen (Detection of lesions using fluorescence molecular imaging)

      Recruiting
      • Unknown Primary Tumors
      • Oropharynx Cancer
      • Detection of lesions using fluorescence molecular imaging
      • Groningen, Netherlands
        University Medical Center Groningen
      Oct 20, 2023

      Oncology Trial in Berlin (moderate Whole Body Hyperthermia (mWBH))

      Recruiting
      • Oncology
      • moderate Whole Body Hyperthermia (mWBH)
      • Berlin, Germany
        Klinik für Radioonkologie und Strahlentherapie
      Apr 6, 2023

      Lung Diseases, Interstitial Trial in Worldwide (Pirfenidone, Placebo)

      Completed
      Has Results
      • Lung Diseases, Interstitial
      • Camperdown, New South Wales, Australia
      • +65 more
      Dec 22, 2020

      Immune Biomarker Study for Salivary Gland Carcinoma

      Not yet recruiting
      • Salivary Gland Tumor
      • Benign Salivary Gland Tumor
      • Sampling
      • Erlangen, Bavaria, Germany
      • +1 more
      Sep 21, 2023

      Advanced Solid Tumor Trial (HS-20093)

      Not yet recruiting
      • Advanced Solid Tumor
      • (no location specified)
      Oct 29, 2023

      Malignant Tumor, Positron Emission Tomography, Fibroblast Activation Protein Inhibitor Trial in Beijing (68Ga-TCR-FAPI PET/CT)

      Recruiting
      • Malignant Tumor
      • +2 more
      • 68Ga-TCR-FAPI PET/CT
      • Beijing, China
        Peking University Cancer Hospital
      Oct 19, 2023

      Meningioma, Refractory Meningioma, Relapsed Meningioma Trial in Omaha (ONC201)

      Not yet recruiting
      • Meningioma
      • +2 more
      • Omaha, Nebraska
        University of Nebraska Medical Center
      Aug 21, 2023

      Solid Tumor Trial (LM103)

      Not yet recruiting
      • Solid Tumor
      • LM103
      • (no location specified)
      Jul 25, 2023

      Solid Tumor Trial (LM103)

      Not yet recruiting
      • Solid Tumor
      • LM103
      • (no location specified)
      Jul 25, 2023